mHealth and application technology supporting clinical trials: Today's limitations and future perspective of smartRCTs

18Citations
Citations of this article
71Readers
Mendeley users who have this article in their library.

Abstract

Nowadays, applications (apps) for smartphones and tablets have become indispensable especially for young generations. The estimated number of mobile devices will exceed 2.16 billion in 2016. Over 2.2 million apps are available in the Google Play store®, and about 1.8 million apps are available in the Apple App Store®. Google and Apple distribute nearly 70,000 apps each in the category Health and Fitness, and about 33,000 and 46,000 each in medical apps. It seems like the willingness to use mHealth apps is high and the intention to share data for health research is existing. This leads to one conclusion: the time for app-accompanied clinical trials (smartRCTs) has come. In this perspective article, we would like to point out the stones put in the way while trying to implement apps in clinical research. Further, we try to offer a glimpse of what the future of smartRCT research may hold.

Cite

CITATION STYLE

APA

Vogel, M. M. E., Combs, S. E., & Kessel, K. A. (2017). mHealth and application technology supporting clinical trials: Today’s limitations and future perspective of smartRCTs. Frontiers in Oncology, 7(MAR). https://doi.org/10.3389/fonc.2017.00037

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free